Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies
Published on: June 30, 2023
Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies
Evita Muller1, Leo Feinberg1,2, Małgorzata Woronkowicz3,4
1West of England Eye Unit, Royal Devon University Healthcare NHS Foundation Trust, Exeter EX2 5DW, UK.
Corneal neovascularization (CoNV) is a vision-impairing condition. This review explores therapeutic targets and strategies, including gene therapy and combination treatments, for managing CoNV and improving visual outcomes.
Area of Science:
- Ophthalmology
- Angiogenesis Research
- Corneal Disease
Background:
- Corneal neovascularization (CoNV) disrupts the avascular cornea, impairing vision.
- Multiple factors like infection, inflammation, hypoxia, and trauma trigger CoNV.
- CoNV significantly reduces visual acuity and quality of life.
Purpose of the Study:
- To review potential therapeutic targets for CoNV.
- To explore current and emerging treatment strategies for CoNV.
- To highlight the need for multifaceted and combination therapies.
Main Methods:
- Literature review of CoNV pathophysiology and treatments.
- Analysis of pro- and anti-angiogenic factors.
- Evaluation of current therapies (corticosteroids, anti-VEGF, laser) and emerging options (immunosuppressants, drug delivery systems, gene therapy).
Main Results:
- CoNV is driven by complex angiogenic factor interplay.
- Current treatments include topical steroids, anti-VEGF, and laser modalities.
- Emerging therapies show promise, including gene-based approaches (Aganirsen, CRISPR/Cas9) and advanced drug delivery.
Conclusions:
- Targeting angiogenic mediators offers therapeutic potential for CoNV.
- Combination therapies are likely necessary for optimal management due to CoNV's multifactorial nature.
- Further research and clinical trials are crucial for effective CoNV treatment and remission.
Related Concept Videos
Persuasion Strategies
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Electrical Current

